bifunctional anti-HER3 apoptotic peptide (Lynntech)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namebifunctional anti-HER3 apoptotic peptide (Lynntech)
Drug Alias NameAHAP (Lynntech)AHAP
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 modulators
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLynntech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLynntech Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A